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PREFACE

This thesis is written in the style required by The American Society for
Microbiology for the Journal of Cellular and Molecular Biology, to which a portion will
be submitted for publication.
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ABSTRACT

Multi-drug-resistant bacteria are a major cause of hospital-acquired infections and
antibiotic resistance in these organisms is often plasmid mediated, which has become a
growing concern. Plasmids conferring resistance to multiple antibiotics are increasingly
becoming a common source of antibiotic resistance. The behavior of these plasmids
under and in the absence of selective pressure is not yet fully understood. Therefore, to
determine the behavior of a multiple-resistance plasmid under selective pressure pCR
2.1-TOPO, a commercial plasmid, was inserted into an Escherichia coli host and grown
in a continuous culture under four conditions: broth with 1) kanamycin alone, 2)
ampicillin alone, 3) with both kanamycin and ampicillin, and 4) without antibiotics.
Samples were taken every two weeks, frozen, and later cultured on a replica plate series
to identify mutants whose plasmids no longer conferred resistance to one or both
antibiotics. The plasmids of these mutants were isolated, sequenced, and compared. The
sequence data were analyzed to determine how the plasmid-mediated resistance genes
changed over time. These results show the effects of selection pressure on the plasmid
itself rather than on the organism by antibiotics and relates to the overall problem of
antibiotic resistance in medicine and animal science by contributing to the understanding
of the persistence of resistance markers in pathogen populations.
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INTRODUCTION

Multi-drug-resistant bacteria are a major cause of hospital-acquired infections and
antibiotic resistance in these organisms is often plasmid mediated, which has become a
growing concern1. Plasmids conferring resistance to multiple antibiotics are increasingly
becoming a common source of antibiotic resistance2. The behavior of these plasmids
under and in the absence of selective pressure is not yet fully understood3. To better
understand this behavior this study examined the effects of long-term exposure to
antibiotics on plasmid-mediated antibiotic resistance genes.
The plasmid pCR 2.1-TOPO (Figure 1) carries genes conferring resistance to
kanamycin via aminoglycoside 3´-phosphotransferase and ampicillin via penicillinbinding protein 1A. The TOP10 (Invitrogen, Carlsbad, CA) strain of Escherichia coli was
transformed with the pCR 2.1-TOPO plasmid and isolated using blue/white screening.
From this isolated colony, four continuous cultures were established in Luria-Bertani
(LB) broth media with kanamycin alone, ampicillin alone, both antibiotics, or without
antibiotics at concentrations known to inhibit the growth of susceptible TOP10 E. coli.
Samples of the continuous cultures were taken and frozen every two weeks and the
minimum inhibitory concentration (MIC) later determined using Etest strips for each
sample to kanamycin and ampicillin. To identify mutations that caused changes in MIC,
each saved sample was cultured on a replica plate series and the MICs determined for the
unique colonies isolated. The plasmids of these cultures were isolated and shipped to
GeneWiz (South Plainfield, NJ) for nucleotide sequencing. The sequence data were
analyzed using the Molecular Evolutionary Genomic Analysis (MEGA) tool. Lastly,
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resistance to antibiotics to which the isolated samples were previously susceptible was
regained by culturing the samples in sub-inhibitory concentrations of the antibiotics.

Introduction to Plasmid Biology
Conjugation is the most common and powerful method of horizontal gene
transfer, in which plasmids are transferred between individual bacteria4. Plasmids, which
are small, autonomous, extra-chromosomal pieces of DNA, can be considered the trading
cards of bacterial cultures. Bacterial chromosomes contain the basic genes necessary for
the proper growth and replication of the cell. These genes are the tried-and-true tools
bacterial species have used to survive for millennia and which have undergone little
change over time.
In contrast, plasmids are distinctly separate from the chromosome and tend to
contain genes that confer traits such as resistance to antibiotics and other substances,
metabolism of complex compounds or the production of such molecules, virulence
factors, and other miscellaneous properties that are usually only transiently valuable to
the cell5. Like trading cards, these plasmids can be gained as they become valuable in
environments in which they are needed or lost when their value no longer merits the cost
incurred by carrying them6. Due to the numerous functions plasmids may confer upon
their hosts, especially the ability to confer resistance to antibiotics, and their current use
in the study of molecular biology, the study of plasmids is an important avenue of
research. For the purposes of this study, plasmid biology is presented as the history,
classification, replication control, replication, inheritance, dissemination, and the clinical
importance of plasmids. The methods of replication control, replication, inheritance, and
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dissemination of plasmids vary and therefore general patterns for these processes will be
discussed before discussing the method used by the pCR 2.1-TOPO plasmid used in this
study.

History of Plasmid Research
The term plasmid was coined by Joshua Lederberg in 1952 in the journal
Physiological Reviews, in which he stated,

“These discussions have left a plethora of terms adrift: pangenes, plastogenes,
chondriogenes, cytogenes and proviruses, which have lost their original utility
owing to the accretion of vague or contradictory connotations. At the risk of
adding to this list, I propose plasmid as a generic term for any extrachromosomal
hereditary determinant. The plasmid may be genetically simple or complex7.”

Originally, the study of plasmids was limited to microbial geneticists who studied them
as mechanisms of gene exchange, but upon the discovery of their role in the spread of
antibiotic resistance, a much wider audience became interested in plasmids.
Plasmids were discovered during studies conducted in the 1940s and 50s that
were examining recombination in E. coli. These studies found that sexual differentiation
was attributable to the presence or absence of a transmissible factor called F (for
fertility). These cells could be classified as either F+ or F- based on the presence or
absence of the F factor. Invariably, it was found that the transfer of genetic information
was unidirectional: F+ cells transferred genetic information to F- cells, which then became
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F+ themselves7. This pattern of transmission of plasmids through conjugation from cell to
cell was soon discovered to be responsible for another property of microbes that came as
a surprise.
From the very beginning of the use of antibiotics in medicine, laboratories had
been able to isolate resistant strains that had arisen from mutations in the chromosome,
generally arising from point mutations8. These strains arose relatively infrequently. In
striking contrast, soon after the development of single antibiotic resistance in clinical
settings, the appearance and rapid spread of multiple antibiotic resistance plasmids led to
the study of plasmids that today has made them indispensable tools in molecular biology.

Plasmid Classification
In an attempt to organize the large number of plasmids that were being
discovered, with all their functional diversity, a classification system based on the
replication system of the plasmid, a property common to all plasmids, was developed.
This classification system, known as incompatibility grouping, is based on the inability of
two plasmids to co-exist stably in the same cell line if they share the same replication
system as defined by their origins of replication9. Many plasmids produce a repressor that
inhibits replication of the plasmid at sufficient concentrations or an inducer that is
responsible for the induction of replication. This concentration varies from plasmid to
plasmid, but is responsible for the determination of plasmid copy number10. Plasmids that
share the same repressor system will affect each other’s rate of replication by each
producing the repressor until the concentration of repressors is high enough to inhibit
replication. The total number of plasmids will be approximately the same as if a single
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plasmid were present despite the presence of two distinct plasmids11. Upon fission of the
cell, the distribution of plasmids of each type to the daughter cells occurs at random. This
leaves the plasmid composition of each cell to chance, eventually producing daughter
cells containing a single plasmid. This is only a general pattern; however, as some
plasmids of the same incompatibility group may not have the same copy number, and, in
such cases, the plasmid at the higher copy number will out-replicate their competitors and
in other plasmids, partitioning systems for the distribution of plasmids between daughter
cells exist. In contrast, plasmid pairs that are not in the same incompatibility group do not
have repressors that inhibit replication of the opposite plasmid and their relative
contribution to the extra-chromosomal gene pool and copy number are consistent from
generation to generation11. This system for the classification of plasmids is not without its
weaknesses. Some plasmids contain more than one origin of replication that interferes
with the ability of incompatibility testing. Other plasmids may have mutations that cause
otherwise-incompatible and evolutionarily related plasmids to be considered
compatible11. Other methods utilizing molecular probes are able to determine the
presence of multiple replicons and small mutations within the replicon in order to more
accurately classify plasmids into incompatibility groups9.

Control of Plasmid Replication
The replication of plasmids independent of their host chromosome is one of their
defining characteristics; however, their actions are not orchestrated entirely without
regard to the proceedings of their hosts. In order to persist within a population, the
replication rate of the plasmid cannot be sustained at a rate greater than that of the host
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cell to prevent the risk of imposing a detrimental cost upon the host. Conversely, the
replication rate cannot be sustained at less than the rate of host cell division which would
eventually produce cells that lack the plasmid. The mechanisms by which replication is
controlled are, therefore, an important aspect of plasmid biology. The models that have
been proposed to explain the controlled replication of plasmids can be divided into two
categories: passive and active12.
Passive control strategies are those in which the plasmid copy number is limited
by an external constraint. This may be a host-encoded protein that is essential for the
initiation of replication13. In light of the incompatibility groups discussed previously, it is
unlikely that a single host-encoded factor could be responsible for the regulation of the
replication of plasmids. However, in natural environments with limited nutrient
availability, passive control of plasmid replication due to the limitations of the cell’s
resources can influence the plasmid replication rate and copy number12.
For active control systems, control of the rate of plasmid replication is determined
by genes encoded within the plasmid itself. Two model systems for the control of
replication rates have been proposed: the inhibitor dilution model and the autorepressor
model, which differ in the encoded replication control gene being either a repressor or
initiator of replication14. In the inhibitor dilution model, replication inhibitors are
produced at a concentration proportional to plasmid copy number. The inhibitors function
by binding to the origin of replication. Some inhibitors, instead of binding to the origin of
replication, will bind to plasmid encoded initiators to inhibit the synthesis of proteins
necessary for the initiation of replication. At a low plasmid copy number, inhibitor
concentration is also low, which leaves the origin or initiator predominately unbound by
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inhibitors, and replication of the plasmid is able to proceed. At higher copy numbers,
inhibitor concentration is also higher and results in the inhibitor binding to the origin or
initiator, thereby preventing further replication of the plasmid until the inhibitor
concentration decreases when the cell either grows larger or divides14.
In the autorepressor model, replication of the plasmid is meditated by an initiator
protein that binds to the origin of replication and initiates replication. Within the operon
coding for the initiator is also an autorepressor that is co-transcribed with the initiator.
The autorepressor regulates the rate of transcription of both proteins by binding to the
promoter-operator region of the autorepressor/initiator operon, and thereby maintains a
constant concentration of both proteins. In some cases the autorepressor and initiator are
a single bi-functional protein15.
The plasmid pCR 2.1-TOPO contains the pUC origin of replication which is a
derivative of the pMB1 origin of replication. The pMB1 origin does not require plasmidencoded functions for its replication. It instead relies on replication enzymes produced by
the host cell16. The pUC origin of replication within the pCR 2.1-TOPO plasmid also
requires host enzymes for replication; however, the loss of the rop gene, responsible for
regulation of the plasmid copy number, and a mutation in the rep gene, responsible
initiation of replication, result in a copy number of 500-700 plasmids per cell17. This
property is useful for the purposes of this study as the aim is to determine the effects of
long-term exposure to antibiotics on the resistance genes themselves. Complications
arising from mutations to other plasmid-encoded proteins are thereby avoided. However,
this large copy number also makes the detection of mutations within a single plasmid
extremely hard to isolate unless the plasmid with the mutation becomes the dominant
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plasmid within the cell, as the phenotype of the bacteria is determined by the sum of the
actions of the total plasmid population within that bacterial cell. With few plasmids
carrying the mutation that would make the cell susceptible to an antibiotic, it is not until
many generations after the mutation arises that it could be observed.

Plasmid Replication
The replication of plasmids is controlled, as discussed previously, at the level of
initiation in a manner specialized for the maintenance of plasmids at an appropriate copy
number; however, once replication is initiated, it proceeds in a manner very similar to
that of chromosomal replication. Plasmid replication begins with the binding of a Rep
protein, specific for the replicon present in the plasmid, to the interon sequence located
near the origin of replication. Interons are short, repeated DNA sequences that, when
bound by the Rep protein, separate the adjacent DNA sequence high in adenine and
thymine12. This allows DNA helicase enzymes to enter the melted portion and further
unwind the DNA template to reveal sites for the binding of the primer and the initiation
of replication. The Rep protein and helicase enzymes are referred to as the pre-priming
complex. Once the primer site is revealed, a primase enzyme synthesizes an RNA primer.
The RNA primer is then extended with DNA by the enzyme DNA polymerase III in the
leading and lagging strands10.
There are a few special mechanisms for plasmid replication that are markedly
different from the process described above. Rolling circle replication is a common form
of replication in high-copy-number plasmids of Staphylococcus, Lactobacillus,
Mycoplasma, Streptococcus, and Streptomyces. During rolling circle replication, the Rep
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protein makes a single stranded break at the origin or replication while maintaining its
attachment to the 5´-terminus of the break. The exposed 3´-terminus serves as a primer
for the leading-strand DNA to be extended by DNA polymerase. RNA polymerase forms
an RNA primer on the lagging strand at the palA locus, a point in the plasmid where a
hairpin loop forms in the displaced strand. The lagging strand is then extended by DNA
polymerase18.
Another mechanism, called theta replication, in which there is no requirement for
a plasmid-encoded Rep protein, is common in Col plasmids and other related multicopy
plasmids. The initiation of theta replication begins with the transcription of a preprimer
RNA approximately 555bp upstream of the origin of replication by RNA polymerase.
The RNA transcript elongates as RNA polymerase travels towards the origin of
replication and folds into a configuration which assists in the formation of a stable RNADNA hybrid at the origin of replication. Next, an endonuclease catalyzes the cleavage of
the RNA strand of the RNA-DNA complex at the origin of replication, leaving behind
what is essentially a primer, though not one produced by RNA primase. The 3´-terminus
of the RNA transcript left behind after the cleavage of the RNA from the RNA-DNA
complex is then extended by DNA polymerase. Downstream of the origin, unwinding
reveals a primosome assembly site where lagging-strand synthesis is initiated10.
The plasmid pCR 2.1-TOPO contains the pUC origin of replication. This origin of
replication utilizes theta replication. As mentioned previously, the pCR 2.1-TOPO
plasmid does not encode any of its own replication enzymes, and therefore uses the host
cells RNA polymerase, endonucleases, DNA polymerase, and other enzymes required for
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replication. The benefits and drawbacks of this with regard to this study were discussed
previously.

Control of Plasmid Inheritance
For a plasmid to exist stably within a population, it must be inherited by both
daughter cells reliably during cell division. This requires that the plasmids must replicate
on average once per generation. Once the plasmid has replicated, the products of
replication must be distributed between both daughter cells when the cell undergoes
division. If this is not accomplished, a daughter cell receiving no plasmid DNA at cell
division would give rise to a clone of plasmid-free descendants. There are different
strategies used by high- and low-copy-number plasmids to deal with this issue.
Upon division of a bacterial cell, only extremely infrequently is there an instance
in which one of the daughter cells does not receive a copy of the chromosome. This
implies that there is a mechanism in place to ensure the equal distribution of
chromosomal DNA. For low-copy-number plasmids, similar mechanisms are
required to ensure the inheritance of plasmids to daughter cells reliably. Two strategies to
ensure the stable inheritance of low copy number plasmids have been proposed:
equipartition and pair-site partitioning, though each assumes an association between the
plasmid and cell membrane. In equipartition, half of the plasmids are inherited by each
cell. In pair-site partitioning, a single pair of plasmids is partitioned into each daughter
cell while the remaining plasmids are distributed randomly. For plasmids with a
functioning copy number control system this is enough to ensure the continued presence
of the plasmids within the cell line19.
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High-copy-number plasmids tend to segregate to daughter cells by random
distribution. While this is unsuitable for low-copy-number plasmids, high-copy-number
plasmids are able to be stably inherited by random distribution alone19. For a single
plasmid, the probability of being distributed to each daughter cell is 0.5. For a high-copynumber plasmid, the probability of a single daughter cell receiving all of the plasmids
present in 0.5n, where n is the copy number of the plasmid. Since each cell divides into 2
daughter cells, the segregation frequency, or the probability that either one of the
daughter cells will receive no plasmid, is 2(0.5)n 12.
The plasmid pCR 2.1-TOPO has a copy number of between 500 and 700 plasmids
per cell and is distributed randomly to daughter cells17. At such a high copy number, the
probability that the plasmid will not be inherited by both daughter cells is, for the
purposes of this experiment, infinitesimal. That is not to say the presence of the pCR 2.1TOPO plasmid is guaranteed once it enters a cell line. The metabolic load imposed on the
host by the presence of the plasmid, such as the increase in generation time and use of
cell components for replication, accelerates the rate of plasmid loss in the population. For
the plasmid pCR 2.1-TOPO, the fitness cost imposed by the production of antibioticresistance products would, in cultures lacking antibiotics, form a situation in which the
eventual loss of the plasmid would occur as cells lacking the plasmid out-compete their
plasmid-bearing counterparts.
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Methods of Plasmid Dissemination
Plasmids play an indispensable role in the evolution of bacterial species by
providing a reservoir of genetic information transmissible between species. Plasmids can
be transferred between cells in three ways: transduction, transformation, and conjugation.
Transduction occurs when a bacteriophage infecting a cell assembles its protein
coat and bacterial chromosomal or plasmid DNA is inserted instead of phage DNA. The
amount of DNA inserted is determined by the size and shape of the plasmid, with sizes
similar to the phage genome being inserted most efficiently12. The phage protein behaves
as if phage DNA were present and is able to bind to bacterial cells and insert the
chromosomal or plasmid DNA. Once in the cell, plasmids need only regain their previous
conformation to re-initiate autonomous replication. This method of horizontal gene
transfer generally occurs in closely related species of bacteria, as the receptors for phage
entry must be similar, and, therefore, it is likely that transduction is a less important
means of gene transmission than conjugation, though transduction of plasmid DNA has
been demonstrated in soil, fresh water, and waste water environments20.
Transformation is the genetic alteration of a cell resulting from the uptake,
integration, and expression of heterologous stretches of exogenous DNA from the
surroundings through the cell membrane. Transformation is commonly used in molecular
biology procedures to force cells to express foreign DNA; however, the procedures used
in this process are not encountered in nature20. Natural transformation does occur and
proceeds in several stages. The first stage is the acquisition of competence, or the ability
to be transformed. This is accomplished in Gram-positive bacteria by accumulating a
specific low-molecular-weight protein, a competence factor, from the local environment.
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The next stage in transformation is the binding of DNA to the cell surface. Gramnegative species do not accumulate competence factors and, instead, undergo a period of
unbalanced growth at the very end of the exponential phase of growth just before the
stationary phase, during which the cells express genes for membrane-associated double
stranded DNA binding proteins. Next, the DNA is transferred into the cell, and, finally, is
integrated. The integration of plasmid DNA is easier than fragments of chromosomal
DNA, as plasmids do not need to be integrated into the host chromosome to function12.
The third mechanism of horizontal gene transfer, conjugation, is the transfer of
plasmids between individuals via cell-to-cell contact. This gene exchange can occur
between an enormous variety of bacterial species. A large number of conjugation systems
have been identified in both Gram-negative and Gram-positive species. The plasmids that
encode for their own conjugative factors are restricted by their size and tend to exist at
low copy numbers to avoid an excessive metabolic cost to the host cell12. The process of
conjugation begins with the synthesis of an extracellular pilus, essential for the
maintenance of the intra-cellular environment that protects the plasmid DNA during
transfer and for cell contact. These pili can be divided into those that are long (1µm) and
flexible or short (0.1µm) and rigid. The type of pilus influences the rate of conjugation in
different situations. After the pilus contacts the recipient cell, the pilus retracts, bringing
the cells into close contact forming the DNA transport pore. Next, a single strand nick is
introduced at the origin of transfer on the plasmid within the donor cell and the nicked
strand is transferred to the recipient cell through the DNA transport pore. Once inside the
recipient cell, the complementary strand is synthesized while the non-donor strand is also
copied so the donor retains an intact plasmid20.
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The plasmid pCR 2.1-TOPO in this study has been transformed into the TOP10
strain of E. coli, which is a strain of E. coli lacking the fertility plasmid, and, therefore,
cannot undergo conjugation. For the purposes of understanding how the antibioticresistance genes present are affected by long-term exposure to antibiotics, this property of
the host E. coli is beneficial. The two factors that should determine the rates of bacteria
carrying the pCR 2.1-TOPO plasmid are the random inheritance at cell division and the
relative fitness of cells containing or lacking the plasmid.

Clinical Importance of Plasmids
Plasmids provide a large reservoir of highly mobile genes which, due to the
restricted size of bacterial genomes, is utilized for the adaptation of bacterial species in
changing environments12. These environments need not be natural, as demonstrated by
one of the best documented examples for plasmid-driven evolution: the spread of
antibiotic resistance.
Resistance to antibiotics was observed almost immediately after the introduction,
mass production, and widespread use of most antibiotics. Typically, resistance was traced
to spontaneous mutations on the bacterial chromosome. This was not seen as a cause for
worry, as the probability of an individual bacterium obtaining mutations that would
confer resistance to multiple antibiotics simultaneously was thought to be very low, and
would only occur in environments where antibiotic exposure was common. To the
surprise of many, transfer of antibiotic resistance between species was soon demonstrated
with the transfer of multiple-antibiotic resistance from Shigella flexneri to E. coli and
Klebsiella pneumonia in a mouse intestine in the absence of antibiotics8. The newly
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discovered transfer of multiple antibiotic resistance between species stimulated interest in
the subject and it was discovered that this resistance was independent of the chromosome.
Soon, the transfer of resistance was compared to the activity of F plasmids and the
plasmid-borne nature of antibiotic resistance was discovered.
That is not to say that all antibiotic resistance is plasmid mediated. Methicillin
resistant Staphylococcus aureus (MRSA), for example, gains resistance to methicillin via
a mutation in the gene encoding the penicillin binding protein. Further accumulation of
resistance determinants from transposons led to the resistance of MRSA to many other
antibiotics, leading to its current notoriety in clinical settings21. Despite this, antibiotic
resistance plasmids are an important source of antibiotic resistance. In studying antibiotic
resistance plasmids, it is important to understand how plasmids gain resistance genes,
how these plasmids spread among bacterial species and interact with human populations,
and how these genes persist within populations that are no longer exposed to antibiotics.
Unlike the point mutations that resulted in methicillin resistance in
Staphylococcus aureus, the acquisition and loss of resistance genes on plasmids occurs as
whole genes and gene blocks are reshuffled within plasmids and the host chromosome,
generally due to the actions of transposons. Transposons come in two classes, known as
Class I and Class II transposons. Class I transposons are also referred to as “copy-andpaste” transposons as they copy themselves and are inserted into a new position. Class II
transposons are also known as “cut-and-paste” transposons. These transposons are able to
excise themselves from the sequence of DNA and insert in a new place12. Regardless of
which type of transposon is present, when a transposon is inserted on both sides of an
antibiotic resistance gene, it forms a composite transposon that is able to be copied or
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excised as a whole, mobilizing the resistance gene. Once this composite transposon is
inserted into a plasmid, it becomes an antibiotic-resistance plasmid. If a resistance gene is
already present on the plasmid, a multiple resistance plasmid is formed. These
transposons can also move from plasmid to plasmid, making the development of multiple
antibiotic resistance plasmids even more rapid, especially in the presence of high levels
of antibiotics selecting for the presence of the resistance genes22.
Antibiotic-resistance genes are transferred to populations of pathogens that
interact with human populations in a variety of ways. The significant selective pressure
exerted on antibiotic resistance genes in healthcare settings, the agricultural use of
antibiotics, and ecological exposure to antibiotics all contribute to the transmission of
antibiotic-resistance genes from the non-pathogenic environmental organisms and
contribute to the selection pressure for antibiotic-resistance genes to persist in microbial
populations.
Antibiotic-resistance genes are commonly found in hospital settings and, once
introduced, these genes are known to spread rapidly23. There are several properties of the
environment of hospitals that influence this rapid spread of resistance genes. Many of the
bacteria that cause problems in hospitals are those that are present even in healthy
individuals, however, when these bacteria acquire resistance genes and antibiotic
treatments kill off other normal flora, they can cause life-threatening infections as they
proliferate to fill the now-empty niches of their competitors24. Meanwhile, the high rate
of antibiotic use for treatment of infections, as well as for prophylaxis during surgical
procedures, generates a high level of selection for resistant phenotypes. Once the resistant
phenotypes are present, hospital staff may act as a vector for the transmission of
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pathogens between patients. With patients constantly entering and leaving the hospital
environment and hospital staff potentially transmitting resistant bacteria between patients,
resistance genes are able to enter into the community and, due to the chronic nature of
many illnesses, other hospitals if the patient is re-admitted while still carrying resistant
bacteria23.
It is estimated that over 70% of the antibiotics used in the United States are not
used to treat infections, but as a growth enhancer for agricultural purposes25. These
practices have been banned elsewhere due to the propensity of this practice to generate
antibiotic resistance. Use of antibiotics for growth enhancement is at sub-therapeutic
levels, that is, levels that are insufficient to kill the susceptible microorganisms. This
allows the susceptible populations to gain resistance in a step-wise fashion utilizing small
phenotypic changes over time, whereas therapeutic doses are high enough that a sudden,
large phenotypic change is required26. This becomes a problem when resistance gained
by agricultural organisms is transferred to human populations27. The use of avoparcin in
the European Union is a prime example of this process at work. Avoparcin, an analogue
of vancomycin, was used extensively in feed on poultry and pig farms. In the mid-1990s
a study of the rates of vancomycin-resistant Enterococci (VRE) in Denmark showed that
pigs and poultry on farms where avoparcin was used as a growth promoter were three
times as likely to carry VRE. Even after the use of avoparcin was banned in 1997, the
rates of VRE remained above the levels observed in areas that were isolated from the
avoparcin use. Countries that were in contact with countries that used avoparcin also saw
a rise in VRE isolates without actually using avoparcin themselves28.
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Many antibiotics are isolated from soil bacteria that naturally produce them. The
restrictions on nutrient availability and space for soil microbes has led to fierce
competition between species and these bacteria have evolved a large armament of
chemical weapons we call antibiotics. In addition to the production of antibiotics,
mechanisms of resistance have evolved in soil bacterial to the antibiotics produced by
themselves and other species. Although not all are useful for the treatment of infectious
diseases, antibiotics isolated from soil bacteria are an important source of antibiotics29.
Streptomycin, the first aminoglycoside antibiotic, was isolated from the soil bacterium
Streptomyces griseus and current searches for novel antibiotics are being conducted in
several labs using soil bacteria30. The resistance genes found in soil bacteria are also an
important source of the spread of resistance genes into human pathogens. A survey of the
antibiotic resistome, the collection of all the antibiotic resistance genes and their
precursors, of 480 species of soil bacteria showed that there were no antibiotics that were
effective against all species and, on average, each species was resistant to 8 of the 18
antibiotics tested31. These resistance genes in soil bacteria, through the mechanisms
discussed previously, are capable of being transmitted to human pathogen populations.
This becomes a problem when clinical antibiotics are introduced into the environment.
Many antibiotics are cleared from the human body unchanged and can eventually make
their way to environmental bacterial populations25. As with agricultural use at subtherapeutic levels, this environmental exposure to low levels of antibiotic can help to
generate antibiotic resistance that can then be transferred to human populations.
The clinical, agricultural, and environmental exposure of antibiotics all form a
feedback system to generate and spread antibiotic resistance. However, even when the
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use of antibiotics is stopped, resistance can be retained in pathogen populations.
Understanding the factors that contribute to the retention and loss of antibiotic resistance
over time will continue to be paramount to the prevention of the spread and development
of antibiotic resistance. The roles that clinical, agricultural, and soil systems play in the
persistence and spread of resistance genes show that antibiotic-resistance genes tend to
persist in populations even when exposure to the antibiotics themselves has been lowered
to sub-inhibitory levels or removed completely. The reasons for this persistence are not
fully understood but can be attributed to the physical linkage of resistance genes and
evolutionary processes compensating for the burden or carrying resistance genes.
Under the pressure of selection by the use of antibiotics, resistance genes can
form non-random associations that aid in the retention of antibiotic-resistance genes in
the absence of the antibiotic. These genes can cluster on plasmids and conjugative
transposons. If several antibiotic-resistance genes are clustered on a plasmid or
conjugative transposon, the presence of only one of the antibiotics exerts enough
selective pressure that the entire resistance cassette is maintained32. How these clusters of
resistance genes react over time in exposure to antibiotic conditions is not fully
understood.
Keeping in mind that antibiotic resistance genes impose a fitness cost upon the
host bacteria when expressed, it is easy to assume that, in the total absence of antibiotics,
the population would eventually revert to sensitivity to antibiotics as susceptible
individuals are no longer burdened by the imposed fitness cost of producing antibiotics.
Unfortunately, this is not always the case. Compensatory mutations in genes other than
the resistance genes can ameliorate the cost of antibiotic resistance while retaining the
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resistance genes; therefore, when compensatory mutations are coupled with resistance
genes, a high level of fitness can be achieved relative to susceptible competitors.
However, when the compensatory mutations are detrimental to fitness when lacking
resistance genes, the loss of resistance in these individuals causes a reduction of fitness
greater than those individuals in which the compensatory mutation has not occurred and
the resistance genes are still present32. This can establish a one-way street wherein the
evolution of antibiotic resistance is not difficult, and, in the presence of antibiotics, is
necessary, but the loss of resistance imposes a greater fitness cost than retention of the
resistance genes and, therefore, resistance is maintained despite the loss of selection
pressure33.
The activity of antibiotic-resistance genes in the absence of selective pressure is
not yet fully understood and, to this end, I have chosen to subject a multiple-resistance
plasmid to several antibiotic conditions to determine how these genes change over time.
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MATERIALS & METHODS

Obtaining the Ancestral E. coli
The original Top10 E. coli (Invitrogen, Carlsbad, CA) for this project was
transformed by Dr. Yasuhiro Kobayashi and obtained on a Petri dish containing LuriaBertani (LB) media, Xgal, and the transformed E. coli sample, known as a blue/white
screen. From this blue/white screen, a single blue transformed colony was selected and
transferred to a new LB plate and streaked for isolation. A colony selected from the
isolation plate was then placed into 5mL of LB broth with 50µg/mL of kanamycin and
ampicillin and grown overnight at 37˚C while on a gyrorotatry shaker set at
approximately 100 rev/min. All other overnight incubations were conducted in this
manner unless otherwise stated. A 750µl sample of this overnight culture was mixed with
250µl of 60% glycerol and stored at -80ºC to serve as an ancestral record.

Establishment of Continuous Cultures
From the overnight culture, four continuous culture environments were
established. Fifty µL of the overnight culture from the ancestral E. coli were added to 8
culture tubes containing 5mL of fresh LB media. The cultures differed in the antibiotic
content and were designated Con A, Con B, KanA, KanB, AmpA, AmpB, KA A, and KA
B. The replicate cultures were used as a backup in case a culture failed to grow or was
unusable. The positive control group, Con A and Con B, contained no antibiotics. The
kanamycin group, Kan A and Kan B, were cultured in 50µg/mL kanamycin. The
ampicillin group, Amp A and Amp B, were cultured in 50µg/mL of ampicillin. The

21

negative control group, KA A and KA B, were cultured in 50µg/mL of both kanamycin
and ampicillin.

Continuous Culture
At approximately the same time each day, the cultured E. coli were transferred to
fresh media to simulate a continuous exposure to the antibiotics. This was accomplished
by transferring 50µl of the previous day’s culture to 5mL of fresh media containing the
appropriate antibiotics. The distribution of antibiotics in the cultures was maintained
throughout the entire experiment and, therefore, was the same as that used in establishing
the continuous cultures. After the continuous culturing procedure was completed, the
previous day’s cultures were discarded and the new cultures were incubated at 37˚C and
agitated via gyrorotary shaker at approximately 100 rpm.

Freezing Samples for Later Use
At two-week intervals, samples of the continuous culture were frozen for later use
in MIC testing, replica plating, and gene sequencing. Sample preservation was carried out
by mixing 750µl of overnight culture media containing the E. coli to 250µl of 60%
glycerol. Samples were then labeled with the culture designation and date of storage and
stored at -80˚C until needed for later use.

Minimum Inhibitory Concentration Determination
Etest strips (BioMerieux, Durham, NC) were used to determine the MIC of
antibiotics on the frozen samples. Frozen samples were thawed and 50µl were added to
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5mL of LB media and incubated at 37°C overnight. No antibiotics were added during this
culturing. Approximately 24 hours later the samples were removed from the incubator.
Using a 0.5 McFarland standard as a template for the required inoculum turbidity,
varying amounts of the E. coli sample were added to a sterile 0.85% saline solution in a
spectrophotometer cuvette until the absorbance matched the absorbance of the 0.5
McFarland standard. After the correct absorbance was reached, the cuvette was labeled
and placed in a sealed container until all samples were standardized. At this inoculum
density, a confluent lawn of growth was obtained. The amount of culture required to
accomplish the suggested inoculum turbidity varied with each culture, likely due to
variations in culture density from overnight incubation.
The inoculation of Petri dishes to produce a bacterial lawn was accomplished by
dipping a sterile swab in the inoculum suspension, removing excess fluid by pressing the
swab against the inside wall of the cuvette, and carefully streaking the plate in 4
directions, each approximately 45 degrees apart. The plates were then allowed to dry.
Drying occurred primarily while the remainder of the Petri plates to be used were
inoculated or, in the case of the final plates, while the previous plates had Etest strips
applied to them.
On the face of the Etest strip is a label indicating the antibiotic present and a
logarithmic scale used to determine the MIC once growth is visible on the Petri dish. The
back of the Etest strips contain varying amounts of antibiotic corresponding to the scale
on the face of the strip. To apply the Etest strip, it was grasped at the top with flamesterilized forceps, its bottom touched to the Petri dish, and released to fall into proper
position. By placing the Etest strips away from the center of the plate, two Etest strips can
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be placed in an anti-parallel orientation to ensure the formed ellipses do not overlap to
determine the MIC of two antibiotics on the same plate. After inoculation and application
of the Etest strips, the Petri plates were stacked in an inverted position in sets of five and
incubated at 37ºC overnight.
Approximately 24 hours later, once bacterial growth was visible to the naked eye,
the MICs were determined by observing where the inhibition ellipse intersects the Etest
gradient strip. When growth occurred along the entire strip then no inhibition had
occurred and the MIC was reported as equal to or greater then the highest value on the
Etest strip.

Sample Dilution and Replica Plate Series
Replica plating is a technique in which one or more secondary Petri plates
containing a selective marker, in this case the presence or absence of a combination of
antibiotics, are inoculated with colonies from a master plate in such as way that they
retain their spatial orientation.
Initially a master plate was created. The master plate was produced in a nearly
identical manner to the Petri plates used in Etest MIC testing with the exception of
further dilution once the 0.5 McFarland standard inoculum densities were achieved.
Frozen samples were thawed and 50µl were added to 5mL of LB media and cultured
overnight. No antibiotics were added during this culturing. Approximately 24 hours later,
the samples were removed from the incubator. Using the 0.5 McFarland standard as a
template for the required inoculum turbidity, varying amounts of the E. coli sample were
added to a sterile 0.85% saline solution in a spectrophotometer cuvette until the
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absorbance matched the absorbance of the 0.5 McFarland standard. This inoculum was
then further diluted to 1/1000th the original density with sterile 0.85% saline. The cuvette
was labeled and placed in a sealed container until all samples were prepared. At this
inoculum density, the plates formed between 200-300 colonies per plate after 24 hours.
The replica plate series consisted of 5 plates. Plate 1 was the master plate. Plate 2
contained Xgal and kanamycin. Plate 3 contained Xgal and ampicillin. Plate 4 contained
Xgal, kanamycin, and ampicillin. The final plate, plate 5, was a control plate that
contained Xgal, but no antibiotics. Transfer of colonies was accomplished by pressing the
master plate upon a sterile velveteen-covered disk. The velveteen cloth retained an
imprint of the colonies of the master plate. Next, plates 2-5 were sequentially and
carefully inoculated by the velveteen cloth by pressing them onto the cloth while
maintaining the orientation of the plate to match the master plate. The inoculated replica
plate series was then placed into the 37ºC incubator overnight.

Replica Plate Mutant Identification
After plates 2-5 were cultured overnight, photographs were taken of each plate on
a colony counting apparatus. The apparatus consists of a light, a magnifying glass, and a
grid pattern to aid in counting colonies. The light used is indirect so that it does not cause
a glare on the Petri dish. The photographs taken of each colony were then cropped,
centered, and enlarged to highlight the center of the Petri plates. In a manner similar to a
blink comparator used to identify celestial objects as they move against the background
of stars, the pictures of plates 2 and 3 were rapidly oscillated. This rapid oscillation
allowed for the easy identification of mutant colonies that were capable of growth in the
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presence of one but not both antibiotics. Plate 4 was used as a confirmation of the ability
to grow only in the presence of a single antibiotic, while plate 5 was a positive control.

Replica Plate Mutant MIC Determination
Etest strips were used to determine the MIC of the identified replica plate
mutants. Colonies isolated in the replica plate mutant identification step were sampled via
a sterile inoculation loop and then cultured in 5mL LB media without antibiotics and
placed in the 37ºC incubator. Approximately 24 hours later, the samples were removed
from the incubator. From this point forward, the procedure for the determination of the
MIC of the replica plate mutants is identical to that used to determine the MIC of the
frozen samples.

Plasmid Isolation
The preparation of plasmid DNA by alkaline lysis with SDS34 used in this
instance is an alternative to the Wizard Plus SV Miniprep that provided a high plasmid
yield. This plasmid isolation procedure is initiated by inoculating 3mL of TB broth,
containing the appropriate antibiotics at 50µg/mL, with 50µl of saved culture. For
cultures saved during the continuous culture, the antibiotics used were the same as those
used for the continuous culture. For the isolated mutants from the replica plate series, the
antibiotic used was the same as the antibiotic the plate on which the mutant colony was
found. The inoculated TB broth was then cultured overnight at 37°C with shaking at 100
rpm.
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From the overnight culture, 1.5mL were transferred to a sterile 1.5mL
microcentrifuge tube and centrifuged at 12000 rpm for 35 seconds. The supernatant was
then decanted so that only the cell pellet remained. The pellet was stored for 10 minutes
at -70°C. The pellet was thawed for 5 minutes at room temperature. The pellet was then
re-suspended in 150µl of Solution 1 with vigorous vortexing. Three-hundred µl of
Solution 2 were added and mixed by inversion until the cell suspension had cleared,
which took approximately 5 minutes. Two-hundred-fifty µl of Solution 3 were added and
mixed by inversion until no trace of yellow liquid remained. The microcentrifuge tube
was incubated at -20°C for 15 minutes. This chilled microcentrifuge tube was centrifuged
for 12 minutes at 13000 rpm.
The supernatant from this centrifugation was transferred to a new 1.5µl
microcentrifuge tube and 750µl of cold (20°C) isopropanol added. The solution was
mixed by inversion followed by incubation at -20°C for 10 minutes. The plasmid DNA
was isolated by centrifuging at 12000 rpm for 5 minutes. The supernatant was discarded,
and the pellet washed with 300µl of 70% EtOH. After washing, the EtOH was discarded
and any remaining EtOH was removed by vacuum centrifugation. The plasmid DNA was
re-suspended in 150µl of sterile deionized water and stored at -20°C34.

Plasmid Sequencing
The sequencing for this project was conducted by GeneWiz (South Plainfield, NJ)
using ABI 3730xl DNA Analyzers for capillary electrophoresis and fluorescent dye
terminator detection. Florescent dye-terminator sequencing utilizes labeling of the chain
terminator dideoxynucletide triphosphates, ddNTPs, with fluorescent tags, which permit
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sequencing in a single reaction, rather than the four separate reactions used in labeledprimer reaction methods. Each of the four ddNTPs is labeled with a florescent dye that
emits light at a different wavelength. As the sample DNA is separated by size during
capillary electrophoresis, the fluorescently labeled ddNTPs pass through a laser that
causes the fluorescent tags to fluoresce. The wavelength of the resulting fluorescence is
detected by a fluorescence detector and recorded. Initially during the separation of
fragments of DNA and detection of fluorescence, the wavelength peaks tends to be very
close together and determining the correct order of bases is not possible but can be done
manually. For this experiment, the sequence obtained from this florescent dye-terminator
sequencing is then used in primer walking to obtain the sequence of the whole pCR 2.1TOPO plasmid. Primer walking is often used for sequencing DNA fragments between 1.3
and 7 kilobases as the fragments are too long to be sequenced in a single read using the
chain-termination method. This method divides the sequence into several short
sequences, each used to design a primer for the next portion of the sequence which were
then used to form a consensus sequence that represents the total DNA fragment.

Bioinformatics Software Analysis of Sequence Data
The bulk of the previously discussed work was aimed towards the eventual
identification of mutants susceptible to a single antibiotic, isolation of the plasmid
responsible for this phenotype, and the acquisition of the nucleotide sequence of this
plasmid. From these obtained sequences, analysis of the plasmid using bioinformatics
software was possible. Using the Alignment Explorer tool within the Molecular
Evolutionary Genomic Analysis (MEGA) program, the sequences of the manufacturers
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pCR 2.1-TOPO plasmid, the ancestral pCR 2.1-TOPO, and the (Kan) Kan A 12-2-11
were aligned. This alignment was performed using the Multiple Sequence Comparison by
Log-Expectation (MUSCLE) method with a gap penalty of -20 and a gap extension
penalty of -5. The obtained sequences were also mapped using the PlasmaDNA program.

Induction of Resistance in Previously Susceptible E. coli
The E. coli isolated during the replica plate procedure, from here forward referred
to as KanR and AmpR, were determined to be susceptible to the antibiotics to which they
were not exposed during the continuous culture procedure. These E. coli were used to
inoculate LB broth cultures containing the antibiotic they were deemed susceptible to
during the MIC determination of replica plate mutants. The KanR E. coli was used to
inoculate 4 broth cultures containing ampicillin at 2µg/mL, 10µg/mL, 25µg/mL, and
50µg/mL. The AmpR E. coli was used to inoculate 4 broth cultures containing
kanamycin at 2µg/mL, 10µg/mL, 25µg/mL, and 50µg/mL. These cultures were then
incubated overnight. The culture with the highest concentration of antibiotics in which
growth was observed was used to inoculate 4 new cultures with the same antibiotics at
the same concentrations. This process was repeated until resistance growth was observed
in all 4 concentrations of antibiotics for both cultures.
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RESULTS & DISCUSSION

Minimum Inhibitory Concentration Determination
MICs were determined for the samples frozen throughout the experiment using
Etest strips. The results for the MIC determination for kanamycin and ampicillin are
represented in Tables 1 and 2. These MICs were determined during the week of 8 July
2012.
Between the 2nd and 4th weeks of the continuous culture in the positive control
group, the activity of the plasmid to confer resistance to kanamycin and ampicillin
drastically changed. By the 6th week, all resistance to ampicillin was lost in the positive
control group and did not vary significantly throughout the rest of the experiment.
Kanamycin resistance remained at a level below the concentration used during the
continuous culture, ranging between 24 and 64µg/mL, but did not drop to the baseline for
Top10 E. coli lacking the pCR 2.1-TOPO plasmid, whose MIC for both kanamycin and
ampicillin was determined to be 2µg/mL. The reason for the elevated level of resistance
above the baseline for Top10 E. coli has not yet been elucidated; however the determined
MIC could have been affected by the amount of E. coli used to inoculate the plates used
in the MIC determination procedure or the period of time for which the plates were
incubated.
For all treatments other than the control treatment, the MIC of kanamycin and
ampicillin remained at >256µg/mL throughout the duration of the experiment. This is
likely due to the rarity of mutations that would confer lowered resistance to these
antibiotics and the difficulty in detecting these mutants among their resistant cohorts.
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The results of this procedure demonstrate that the pCR 2.1-TOPO multipleresistance plasmid, when exposed to a single antibiotic, retains resistance to both
antibiotics present in the vast majority of the E. coli carrying the plasmid. However, like
other plasmids, when no antibiotics are present for a sufficient period, the plasmid is lost,
as it no longer confers an advantage to the host.

Replica Plate Mutant Identification and MIC Determination
The plates produced in the replica series from the dilution of frozen samples were
evaluated for the presence of colonies that were no longer resistant to both antibiotics.
Fifteen bacterial colonies were isolated that, upon examination using the methods
outlined above, appeared to grow in the presence of a single antibiotic. These 15 samples
were added to LB media lacking antibiotics and grown overnight and then frozen for later
MIC testing.
The 15 samples isolated during the identification of mutants that were able to
grow in only the presence of a single antibiotic were cultured in order to determine the
MICs to kanamycin and ampicillin using Etest strips. The results of the MIC
determination of mutants identified using the replica plate series are listed in Table 3.
Although 15 colonies were originally identified as mutants, only 2 of the colonies, when
re-cultured and tested for MIC to kanamycin and ampicillin, showed susceptibility to a
single antibiotic as indicated by the replica plating procedure. These samples are listed as
KanR and AmpR in Table 3. This procedure demonstrated that, within a large population
of resistant E. coli carrying the pCR 2.1-TOPO plasmid, there will be individuals who
eventually lose resistance to an antibiotic to which they are no longer exposed.
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Bioinformatics Software Analysis of Sequence Data
The sequences obtained via the primer walking process from GeneWiz were
aligned with the manufacturer’s stated sequence for the pCR 2.1-TOPO plasmid as well
as to each other. GeneWiz was able to determine the sequence of the Ancestral 11/4/11
plasmid as well as the sample (Kan) Kan A 12/4/11, designated as KanR. The Alignment
Explorer tool within the MEGA program was used to align the sequences. The sequences
obtained from GeneWiz showed a 100% identity with each other; however, when
compared to the sequence provided by the manufacturer there were gaps in the multiple
cloning site. Upon further examination, it became clear that this gap was caused by the
usage of the EcoR1 restriction enzyme being used with this plasmid. The portion of the
alignment showing these gaps is located in Figure 2. This is unlikely to be the cause for
the phenotypic change in the isolated E. coli, as the multiple cloning site is used for
inserting genes of interest into the pCR 2.1-TOPO plasmid and the antibiotic resistance
genes were both over 1300 bases upstream. This procedure demonstrated that, despite the
presence of the plasmid and the appropriate resistance gene, colonies may be susceptible
to an antibiotic which they have not been exposed.

Induction of Resistance in Previously Susceptible E. coli
The KanR and AmpR E. coli isolated on the replica plate were used to inoculate
LB broth cultures containing the antibiotic to which they were previously deemed
susceptible during the MIC determination of replica plate mutants. The KanR and AmpR
E. coli were used to inoculate 4 broth cultures containing ampicillin or kanamycin at
2µg/mL, 10µg/mL, 25µg/mL, and 50µg/mL and the results of this procedure are listed in
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the Day 1 row of Table 4. The culture with the highest concentration of antibiotics in
which growth was observed, from the 2µg/mL culture of the KanR E. coli and the
25µg/mL culture of the AmpR E. coli, were used to inoculate 4 new cultures with the
same antibiotics at the same concentrations. After overnight incubation, the Day 2
cultures were capable of growth in all four antibiotic concentrations. This procedure
demonstrated that susceptible E. coli containing the appropriate resistance gene can
quickly regain resistance upon exposure to the appropriate antibiotic.

Discrepancies between Hypothesized and Actual Results
Initially, I had hypothesized that, after 6 months of exposure to a single antibiotic,
the vast majority of the E. coli present in the culture would have become susceptible to
the antibiotic to which it had not been exposed through accumulated mutations in the
resistance gene that was not under selective pressure to be maintained. Through the MIC
determination of the saved cultures, it is obvious that this did not occur, as all samples in
which any antibiotics were present retained resistance to both antibiotics. Further
contradicting this hypothesis, the isolation of mutants that were resistant to a single
antibiotic, while susceptible to the antibiotic to which they were not exposed showed that
these mutants were rare within the populations and when the sequences of the plasmids of
the isolated E. coli were compared to the sequence of the plasmid used to start the
continuous culture, the resistance genes had not accumulated any mutations. The reasons
for this behavior are not clear; however, I believe it is possibly due to linkage of the
resistance genes, compensatory mutations, or the very high copy number of the pCR 2.1TOPO plasmid.
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CONCLUSIONS

This study aimed to examine the effects of long-term exposure to antibiotics on
plasmid-mediated antibiotic-resistance genes. This was achieved by continuously
culturing E. coli containing a multiple-resistance plasmid in different antibiotic
combinations. The MIC of these cultures was determined at regular intervals and upon
finding no change in the MIC of cultures regardless of the antibiotic to which they were
exposed, as long as they were exposed to an antibiotic, a replica plating procedure was
used to isolate any mutants that were resistant to a single antibiotic. The E. coli isolated
during this procedure, KanR and AmpR, as well as the plasmid from the E. coli used to
start the continuous culture, had their plasmids isolated. The isolated plasmids were
shipped to GeneWiz so that the nucleic acid sequences could be determined using primer
walking. The obtained sequences were compared showing that the kanamycin and
ampicillin resistance genes were still present in both of the isolated samples and were
identical to the genes present before the continuous culture procedure. These samples
were then cultured in the presence of the antibiotic to which they were deemed
susceptible in order to induce resistance to the antibiotic.
In summary, this experiment has shown that multiple-resistance plasmids tend to
retain resistance to any antibiotics to which the plasmid confers resistance as long as one
of the antibiotics in question is present. In a relatively small number of individuals, the
expression of the resistance gene is reduced and may ultimately be stopped when the
corresponding antibiotic is not present for long periods of time; however, upon re-
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exposure to the antibiotic, expression of the gene and resistance to the antibiotic are
quickly regained.
To improve upon this project, several changes could be made. First, using a
plasmid with a lower copy number would aid in identifying colonies in which with
mutations have arisen or expression of the resistance gene has been reduced. Second,
using sub-inhibitory concentrations of antibiotic as one of the treatments during the
continuous culture would be useful in determining if the plasmid would be retained and
in its original form when antibiotics are present in sub-inhibitory concentrations. Third,
using a plasmid that confers resistance to more than 2 antibiotics would help in
determining the exact relationship between the genes present and how the maintenance of
one gene affects the others. Fourth, using minimally nutritious media in order to increase
the relative cost of carrying the plasmid would aid in making the plasmid a burden on the
host so that the plasmid and its resistance genes would be more likely to mutate and
become non-functional as a mechanism of ameliorating the associated fitness cost.
Finally, using a plasmid whose resistance genes are farther apart would help in
determining the role the spatial arrangement of the resistance genes on the retention of
resistance genes when the antibiotic is no longer present.
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FIGURES
Figure 1. pCR 2.1-TOPO plasmid map generated with PlasmaDNA of manufacturer’s
provided sequence.
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Figure 2. MEGA alignment results of the manufacturer’s stated sequence of the pCR 2.1TOPO plasmid with the reported sequence from GeneWiz for the KanR and Ancestral
plasmids showing the gaps located in the multiple cloning site.
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TABLES

Table 1. Minimum inhibitory concentration of kanamycin for each treatment over the
course of six months in µg/mL. Asterisks (*) signify that colonies were present in the
formed ellipse. For colonies in which no ellipse was formed, resistance was reported as
>256µg/mL.

Date Saved
11/4/2011
11/18/2011
12/2/2011
12/16/2011
12/30/2011
1/13/2012
1/31/2012
2/14/2012
2/28/2012
3/13/2012
3/27/2012
4/10/2012
4/23/2012

No antibiotics
Control
Control
A
B
>256
>256
>256*
>256*
24*
48*
32
64*
32
48
24
48
64*
64
32
48*
48
48
64
96
48
32
32
32
64
64

MIC tested against Kanamycin
Kanamycin
Ampicillin
Kan A
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
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Kan B
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

Amp A
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

Amp B
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

Kan and Amp
KA A
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

KA B
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

Table 2. Minimum inhibitory concentration of ampicillin for each treatment over the
course of six months in µg/mL. Asterisks (*) signify that colonies were present in the
formed ellipse. For colonies in which no ellipse was formed, resistance was reported as
>256µg/mL.

Date Saved
11/4/2011
11/18/2011
12/2/2011
12/16/2011
12/30/2011
1/13/2012
1/31/2012
2/14/2012
2/28/2012
3/13/2012
3/27/2012
4/10/2012
4/23/2012

No antibiotics
Control Control
A
B
>256
>256
>256*
>256*
2*
4*
3*
4*
2
3
0.5
1
1.5*
1.0*
2
2*
4
2
4
3
4
2
2
3
3
3

MIC tested against Ampicillin
Kanamycin
Ampicillin
Kan A
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

Kan B
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
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Amp A
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

Amp B
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

Kan and Amp
KA A
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

KA B
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256
>256

Table 3. Minimum inhibitory concentrations of kanamycin and ampicillin for samples
isolated from the replica plate series. For colonies in which no ellipse was formed,
resistance was reported as >256µg/mL.

E. coli
KanR
AmpR

Replica Plate Mutant MIC Results
Kanamycin Resistance
Ampicillin Resistance
(µg/ml)
(µg/ml)
>256
2
2

>256
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Table 4. Induction of antibiotic resistance in previously susceptible E. coli after
overnight exposure to antibiotics showing growth as + or – for a given culture. KanR E.
coli is the (Kan) KanA 12/2/11 sample obtained in the replica plate procedure. AmpR E.
coli is the (Amp) AmpB 3/31/12 sample obtained in the replica plate procedure.

Day
1
2

Induction of Antibiotic Resistance
Antibiotic Concentration in Broth
E. Coli
10µg/mL 25µg/mL
50µg/mL
100µg/mL
+
KanR E. coli
I
AmpR E. coli
KanR E. coli
AmpR E. coli

+

+

+
+

+
+
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I

-

-

+
+

+
+

APPENDIX

Appendices. Sequences of pCR 2.1-TOPO plasmid provided by the manufacturer, from
the colony used to start the continuous culture, and those isolated in replica plate series.

Appendix 1. pCR 2.1-TOPO Sequence from Manufacturer:
AGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATG
CAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGC
AATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGC
TTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGA
AACAGCTATGACCATGATTACGCCAAGCTTGGTACCGAGCTCGGATCCACTA
GTAACGGCCGCCAGTGTGCTGGAATTCGCCCTTAAGGGCGAATTCTGCAGAT
ATCCATCACACTGGCGGCCGCTCGAGCATGCATCTAGAGGGCCCAATTCGCC
CTATAGTGAGTCGTATTACAATTCACTGGCCGTCGTTTTACAACGTCGTGACT
GGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTC
GCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGT
TGCGCAGCCTGAATGGCGAATGGACGCGCCCTGTAGCGGCGCATTAAGCGCG
GCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAG
CGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTC
CCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTA
CGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGC
CATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTT
AATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA

48

TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATG
AGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATTCAGGGCGCAAG
GGCTGCTAAAGGAAGCGGAACACGTAGAAAGCCAGTCCGCAGAAACGGTGC
TGACCCCGGATGAATGTCAGCTACTGGGCTATCTGGACAAGGGAAAACGCAA
GCGCAAAGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGCGATAGCTAG
ACTGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCC
CTCTGGTAAGGTTGGGAAGCCCTGCAAAGTAAACTGGATGGCTTTCTTGCCG
CCAAGGATCTGATGGCGCAGGGGATCAAGATCTGATCAAGAGACAGGATGA
GGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCG
CTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTG
CTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTG
TCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCG
GCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTG
TCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGG
ATCTCCTGTCATCCCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGAT
GCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACC
AAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGT
CGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACT
GTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACC
CATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGG
ATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCG
TTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCT
TCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTAT

49

CGCCTTCTTGACGAGTTCTTCTGAATTGAAAAAGGAAGAGTATGAGTATTCA
ACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTT
GCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTG
CACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAG
TTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTAT
GTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCG
CATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAG
CATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCA
TGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAA
GGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATC
GTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCA
CGATGCCTGTAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACT
ACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAA
GTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGA
TAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGG
CCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGG
CAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGAT
TAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATT
TAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAAT
CTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCC
CGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCT
GCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGA
TCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAG

50

ATACCAAATACTGTTCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAA
CTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTG
CTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTT
ACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCC
CAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTA
TGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTA
AGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAAC
GCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCG
ATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAAC
GCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTT
CCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGA
GGAAGCGGAAG

51

Appendix 2. pCR 2.1-TOPO Ancestral Sequence:
AGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATG
CAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGC
AATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGC
TTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGA
AACAGCTATGACCATGATTACGCCAAGCTTGGTACCGAGCTCGGATCCACTA
GTAACGGCCGCCAGTGTGCTGGAATTCTGCAGATATCCATCACACTGGCGGC
CGCTCGAGCATGCATCTAGAGGGCCCAATTCGCCCTATAGTGAGTCGTATTAC
AATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTAC
CCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCG
AAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGA
ATGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGC
GCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTC
TTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGG
GGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAA
ACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTT
TTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAA
ACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGAT
TTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTA
ACGCGAATTTTAACAAAATTCAGGGCGCAAGGGCTGCTAAAGGAAGCGGAA
CACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAATGTCAGC
TACTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTA
GCTTGCAGTGGGCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGGACAG

52

CAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCC
CTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGG
GGATCAAGATCTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAAC
AAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGG
CTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGG
CTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGC
CCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACG
GGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACT
GGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCCCACCTTGCT
CCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGC
TTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCG
AGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAA
GAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCA
TGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAA
TATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGG
GTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGA
AGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCG
CTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGA
ATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCC
TTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAA
GTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGG
ATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCA
ATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGA

53

CGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTG
GTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAA
GAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTT
ACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAAC
ATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAG
CCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAAC
GTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAAT
TAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGC
CCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGT
CTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGT
AGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACA
GATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAA
GTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGG
ATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGA
GTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTT
GAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCG
CTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAA
GGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAG
CCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGC
TCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTA
CCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTG
AACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGA
ACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGG

54

AGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGC
ACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGT
TTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGG
AGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTG
CTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAA
CCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACC
GAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAG

55

Appendix 3. pCR 2.1-TOPO Sequence from (Kan) Kan A 12-2-11:
AGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATG
CAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGC
AATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGC
TTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGA
AACAGCTATGACCATGATTACGCCAAGCTTGGTACCGAGCTCGGATCCACTA
GTAACGGCCGCCAGTGTGCTGGAATTCTGCAGATATCCATCACACTGGCGGC
CGCTCGAGCATGCATCTAGAGGGCCCAATTCGCCCTATAGTGAGTCGTATTAC
AATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTAC
CCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCG
AAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGA
ATGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGC
GCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTC
TTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGG
GGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAA
ACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTT
TTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAA
ACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGAT
TTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTA
ACGCGAATTTTAACAAAATTCAGGGCGCAAGGGCTGCTAAAGGAAGCGGAA
CACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAATGTCAGC
TACTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTA
GCTTGCAGTGGGCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGGACAG

56

CAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCC
CTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGG
GGATCAAGATCTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAAC
AAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGG
CTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGG
CTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGC
CCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACG
GGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACT
GGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCCCACCTTGCT
CCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGC
TTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCG
AGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAA
GAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCA
TGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAA
TATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGG
GTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGA
AGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCG
CTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGA
ATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCC
TTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAA
GTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGG
ATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCA
ATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGA
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CGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTG
GTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAA
GAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTT
ACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAAC
ATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAG
CCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAAC
GTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAAT
TAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGC
CCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGT
CTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGT
AGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACA
GATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAA
GTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGG
ATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGA
GTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTT
GAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCG
CTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAA
GGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAG
CCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGC
TCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTA
CCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTG
AACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGA
ACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGG
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AGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGC
ACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGT
TTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGG
AGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTG
CTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAA
CCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACC
GAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAG

59

